Adaptive Biotechnologies ADPT Income Statement (2018-2026)

NASDAQ ADPT
$23.95 -0.07 (-0.29%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Adaptive Biotechnologies Quarterly Income Statement

Periods 33 quarters
Latest Jun 2026

Adaptive Biotechnologies reported revenue of $71.55M and net income of -$16.21M for the quarter ended Jun 2026, up 21.5% year over year. This income statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
39.47M37.93M38.62M43.66M47.83M55.20M37.65M48.93M37.92M45.78M41.87M43.19M46.44M47.46M52.44M58.88M93.97M71.68M70.87M71.55M
Cost of RevenueCost of Rev
14.19M14.36M13.19M13.22M14.91M16.59M18.68M17.91M19.35M19.62M18.05M19.32M16.67M18.05M16.98M18.00M18.16M18.22M18.71M20.17M
Gross Profit
25.28M23.57M25.43M30.44M32.92M38.61M18.97M31.02M18.57M26.17M23.82M23.87M29.77M29.41M35.46M40.88M75.82M53.46M52.17M51.39M
Operating items
Amortization - Intangibles
0.43M0.43M0.42M0.42M0.43M0.43M0.42M0.42M0.43M0.43M0.42M0.42M0.43M0.43M0.42M0.42M0.43M0.43M0.42M0.42M
Research & DevelopmentR&D
36.07M34.70M37.84M37.04M35.66M31.22M32.60M32.24M28.53M28.75M30.25M25.35M24.16M23.19M24.20M24.13M23.67M21.76M23.62M19.15M
Share-based Compensation (IS)Stock Comp.
14.67M17.35M15.34M15.56M14.30M12.96M13.52M12.83M12.15M13.36M13.26M12.72M11.93M
Selling, General & AdministrativeSG&A
20.15M23.35M24.14M21.20M20.76M22.43M20.83M22.30M20.08M20.73M19.60M17.90M17.26M18.06M17.40M17.79M17.96M19.56M20.98M21.17M
Restructuring CostsRestructuring
1.04M0.68M0.19M0.09M0.64M
Other Operating ExpensesOther Opex
39.57M41.48M39.70M37.93M36.85M40.73M41.41M42.21M40.27M67.38M39.75M46.58M37.45M39.96M40.45M42.00M42.06M43.13M44.83M47.00M
Operating ExpensesOpex
95.79M99.53M101.69M96.16M93.26M94.38M94.84M96.74M88.88M116.85M90.64M90.51M79.07M81.30M82.05M83.92M83.68M84.45M90.08M87.32M
Operating IncomeOp. Inc
-56.33M-61.60M-63.07M-52.50M-45.43M-39.19M-57.19M-47.82M-50.96M-71.07M-48.76M-47.32M-32.63M-33.84M-29.60M-25.04M10.29M-12.77M-19.21M-15.77M
EBIT
-56.33M-61.60M-63.07M-52.50M-45.43M-39.19M-57.19M-47.82M-50.96M-71.07M-48.76M-47.32M-32.63M-33.84M-29.60M-25.04M10.29M-12.77M-19.21M-15.77M
Non-operating items
Non Operating Interest Expenses
0.65M3.59M3.53M3.61M3.65M3.01M2.99M2.70M2.94M2.95M2.91M2.95M2.97M2.95M2.89M2.69M
Interest & Investment IncomeInt & Inv Inc
0.33M0.24M0.27M0.42M0.77M2.60M3.02M3.61M4.28M4.61M4.22M3.77M3.47M3.07M2.68M2.39M2.23M2.15M2.08M2.26M
Net income details
EBT
-56.00M-61.36M-62.80M-52.08M-45.32M-40.17M-57.70M-47.81M-50.33M-69.47M-47.53M-46.25M-32.10M-33.72M-29.83M-25.59M9.55M-13.58M-20.02M-16.21M
Tax ProvisionsTaxes
Profit After TaxPAT
-56.00M-61.36M-62.80M-52.08M-45.32M-40.17M-57.70M-47.81M-50.33M-69.47M-47.53M-46.25M-32.10M-33.72M-29.83M-25.59M9.55M-13.58M-20.02M-16.21M
Income from Non-Controlling InterestsInc. Minority
-0.10M0.08M-0.06M-0.04M-0.04M-0.04M0.00M0.00M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M0.02M0.02M0.00M0.02M-0.15M
Income from Continuing OperationsIncome (Continuing)
-56.00M-61.36M-62.80M-52.08M-45.32M-40.17M-57.70M-47.81M-50.33M-69.47M-47.53M-46.25M-32.10M-33.72M-29.83M-25.59M9.55M-13.58M-20.02M-16.21M
Consolidated Net IncomeConsol Net Inc.
-56.00M-61.36M-62.80M-52.08M-45.32M-40.17M-57.70M-47.81M-50.33M-69.47M-47.53M-46.25M-32.10M-33.72M-29.83M-25.59M9.55M-13.58M-20.02M-39.94M
Income towards Parent CompanyParent Net Inc
-55.90M-61.43M-62.74M-52.05M-45.28M-40.13M-57.70M-47.81M-50.30M-69.44M-47.51M-46.22M-32.07M-33.69M-29.85M-25.61M9.55M-13.58M-20.03M-39.79M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-55.90M-61.43M-62.74M-52.05M-45.28M-40.13M-57.70M-47.81M-50.30M-69.44M-47.51M-46.22M-32.07M-33.69M-29.85M-25.61M9.55M-13.58M-20.03M-39.79M
Additional items
EPS (Basic)
-0.40-0.44-0.44-0.37-0.32-0.28-0.40-0.33-0.35-0.48-0.33-0.31-0.22-0.23-0.20-0.170.06-0.09-0.13-0.25
EPS (Diluted)
-0.40-0.44-0.44-0.37-0.32-0.28-0.40-0.33-0.35-0.48-0.33-0.31-0.22-0.23-0.20-0.170.06-0.09-0.13-0.25
Shares Outstanding
140.83M140.35M141.70M142.36M142.93M142.52M143.51M144.40M144.70M144.38M145.79M147.41M147.52M147.10M149.20M152.08M152.43M151.72M155.52M159.86M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
140.83M140.35M141.70M142.36M142.93M142.52M143.51M144.40M144.70M144.38M145.79M147.41M147.52M147.10M149.20M152.08M163.16M151.72M155.52M159.86M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
141.03M141.39M142.18M142.78M142.99M143.11M144.28M144.65M144.77M145.08M147.37M147.46M147.56M147.77M151.92M152.23M152.58M153.78M159.70M159.06M
EBITDA
-52.80M-56.70M-58.01M-47.31M-40.05M-33.90M-51.77M-42.17M-45.19M-65.68M-43.13M-42.32M-28.05M-29.48M-24.90M-20.54M14.69M-8.69M-15.40M-12.11M
Interest ExpensesInt Expense
0.65M3.59M3.53M3.61M3.65M3.01M2.99M2.70M2.94M2.95M2.91M2.95M2.97M2.95M2.89M2.69M

Adaptive Biotechnologies Income Statement API

Pull Adaptive Biotechnologies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ADPT&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY